Sirish Dharmapuri

Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy

Sirish Dharmapuri, Umut Özbek, Jung‐Yi Lin et al. · Cancer Medicine · 2020 · 129 citations · Full text

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld et al. · Thrombosis Research · 2020 · 129 citations · Full text

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri et al. · Cancers · 2021 · 78 citations · Full text

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

David J. Pinato, Takahiro Kaneko, Anwaar Saeed et al. · Cancers · 2020 · 74 citations · Full text

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

David J. Pinato, Thomas U. Marron, Pallavi S. Mishra‐Kalyani et al. · European Journal of Cancer · 2021 · 62 citations

Hepatology, Landmark Clinical Trials, Medicine +12